Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
For authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
For authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Anti-TNF. Pulmonary fibrosis.
Email alerts
Anti-TNF. Pulmonary fibrosis.
Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic
Katie L
Druce
,
Kundan
Iqbal
,
Kath D
Watson
,
Deborah P M
Symmons
,
Kimme L
Hyrich
,
Clive
Kelly
RMD Open
Jul 2017,
3
(1)
e000473;
DOI:
10.1136/rmdopen-2017-000473
Special collections
Guidelines, Recommendations and Consensus Statements
Press releases
(1)
